Ultra-hypofractioNated Adjuvant Radiotherapy ± sImultaneous Integrated Boost for Low-risk Breast Cancer Patients
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Radiotherapy Side Effect
Interventions: RADIATION: Ultra-fractionated radiation therapy
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences